全文获取类型
收费全文 | 80773篇 |
免费 | 7881篇 |
国内免费 | 3494篇 |
专业分类
耳鼻咽喉 | 852篇 |
儿科学 | 977篇 |
妇产科学 | 1335篇 |
基础医学 | 10784篇 |
口腔科学 | 2027篇 |
临床医学 | 8250篇 |
内科学 | 13285篇 |
皮肤病学 | 1355篇 |
神经病学 | 4929篇 |
特种医学 | 2810篇 |
外国民族医学 | 19篇 |
外科学 | 9887篇 |
综合类 | 9822篇 |
现状与发展 | 11篇 |
一般理论 | 8篇 |
预防医学 | 5564篇 |
眼科学 | 2118篇 |
药学 | 8324篇 |
37篇 | |
中国医学 | 3532篇 |
肿瘤学 | 6222篇 |
出版年
2024年 | 230篇 |
2023年 | 901篇 |
2022年 | 2016篇 |
2021年 | 2646篇 |
2020年 | 1959篇 |
2019年 | 1729篇 |
2018年 | 2263篇 |
2017年 | 2021篇 |
2016年 | 1836篇 |
2015年 | 2432篇 |
2014年 | 2976篇 |
2013年 | 3253篇 |
2012年 | 4559篇 |
2011年 | 4520篇 |
2010年 | 2966篇 |
2009年 | 2579篇 |
2008年 | 3363篇 |
2007年 | 3445篇 |
2006年 | 3177篇 |
2005年 | 2605篇 |
2004年 | 2154篇 |
2003年 | 2248篇 |
2002年 | 1982篇 |
2001年 | 5235篇 |
2000年 | 4958篇 |
1999年 | 4243篇 |
1998年 | 1565篇 |
1997年 | 1174篇 |
1996年 | 742篇 |
1995年 | 609篇 |
1994年 | 539篇 |
1993年 | 473篇 |
1992年 | 2018篇 |
1991年 | 1735篇 |
1990年 | 1605篇 |
1989年 | 1536篇 |
1988年 | 1345篇 |
1987年 | 1229篇 |
1986年 | 1091篇 |
1985年 | 916篇 |
1984年 | 604篇 |
1983年 | 477篇 |
1982年 | 253篇 |
1981年 | 185篇 |
1980年 | 144篇 |
1979年 | 295篇 |
1978年 | 83篇 |
1974年 | 80篇 |
1973年 | 96篇 |
1972年 | 73篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
J Phua E S C Koay D Zhang L K Tai X L Boo K C Lim T K Lim 《The European respiratory journal》2006,28(4):695-702
Levels of the soluble form of the triggering receptor expressed on myeloid cells (sTREM)-1 are elevated in severe sepsis. However, it is not known whether sTREM-1 measurements can distinguish milder bacterial infections from noninfectious inflammation. The present authors studied whether serum sTREM-1 levels differ in community-acquired pneumonia, exacerbations of chronic obstructive pulmonary disease (COPD), asthma and controls, and whether sTREM-1 may be used as a surrogate marker for the need for antibiotics. Serum sTREM-1 levels in 150 patients with pneumonia, COPD and asthma exacerbations and 62 healthy controls were measured. Serum sTREM-1 levels were significantly elevated in pneumonia (median 295.2 ng x mL(-1)), COPD (280.3 ng x mL(-1)) and asthma exacerbations (184.0 ng x mL(-1)) compared with controls (83.1 ng x mL(-1)). Levels were higher in pneumonia and Anthonisen type 1 COPD exacerbations than in type 2 and 3 COPD and asthma exacerbations. The area under the receiver operating characteristics curve for sTREM-1 as a surrogate marker for the need for antibiotics was 0.77. Serum levels of the soluble form of the triggering receptor expressed on myeloid cells-1 were elevated predominantly in pneumonia and Anthonisen type 1 COPD exacerbations versus type 2 and 3 chronic obstructive pulmonary disease exacerbations, asthma and controls. Serum levels of the soluble form of the triggering receptor expressed on myeloid cells-1 has moderate but insufficient accuracy as a surrogate marker for the need for antibiotics in lower respiratory tract infections. 相似文献
43.
目的探讨利用磁共振波谱成像(MRSI)反映胶质瘤恶性度的价值.方法41例病理证实胶质瘤,原发39例、复发2例,行MR及MRS扫描,MRS数据经残差Z分数统计模型及LLI、Lip/Cho等指标划分肿瘤边界及不同代谢区,并结合MRI结构成像,划分出肿瘤的高代谢活性区、肿瘤浸润边界、坏死区及乏氧区.结果肿瘤浸润边界均超过MR常规图像上的肿瘤边界.Ⅱ级肿瘤高代谢活性区大部分位于肿瘤区内,但Ⅲ、Ⅳ级则大部分位于肿瘤边界;随肿瘤恶性度升高,肿瘤出现了坏死区及乏氧区.结论MRSI对确定肿瘤恶性度及划分肿瘤边界具有一定价值. 相似文献
44.
腰椎终板、椎间盘退变及椎间盘造影疼痛激发试验的相关性研究 总被引:13,自引:1,他引:12
目的探讨下腰痛患者腰椎终板Modic退变、椎间盘退变及CT引导下腰椎间盘造影疼痛激发试验的相关性.方法对45例下腰痛患者常规行腰椎X线和MR检查,分别按Modic终板退变标准(0~3级)与Pearce椎间盘退变标准(Ⅰ~Ⅴ级)对终板和椎间盘进行评估.在CT引导下对45例患者中的40例(120个椎间盘)进行造影和疼痛激发试验,并按Dallas椎间盘造影分级系统(DDD)测评椎间盘退变程度.采用SPSS 11.5统计学软件分析腰椎终板Modic退变、椎间盘退变与腰椎间盘造影疼痛激发试验之间的相关性.结果40例下腰痛患者的腰椎终板Modic分级与椎间盘退变Pearce分级存在较强的相关性(Pearson x^2=43.326,P=0.000),与椎间盘造影疼痛激发试验有显著相关性(Pearson x^2=27.858,P=0.000);椎间盘退变Pearce分级与CT椎间盘造影椎间盘退变Dallas分级也呈较强的相关性.结论腰椎终板Modic退变分级与椎间盘退变Pearce分级密切相关,而与椎间盘疼痛激发试验有显著相关性,提示终板Modic退变可能是下腰痛的原因之一. 相似文献
45.
目的评价牙冠延长术在牙体缺损达龈下的残根残冠修复中的临床疗效。方法自2004年5月至2005年6月,对32例患者的36颗牙体缺损达龈下的患牙,术前按断端位于龈下最深距离分为A组(20颗患牙,距离<3.0mm)和B组(16颗患牙,3.0mm≤距离≤4.0mm),均采用牙冠延长术暴露龈下牙体断面,术后6周行桩冠修复。分别记录和比较手术前、后牙周探诊深度(PD)、菌斑指数(PLI)、龈沟出血指数(SBI)和牙齿松动度,以观察临床疗效。结果术后随访患者6个月,两组病例术后6周牙体断端均暴露较好、龈缘颜色正常,术后修复效果有效率为100%,满意率为77.78%。A组术后无松动,修复效果满意;B组术后50.00%出现Ⅰ度松动,修复效果欠佳,两组修复效果比较差异有显著意义(P<0.05)。术后各阶段两组的PD、PLI、SBI均明显优于术前(P<0.05),但两组术后牙周指数比较差异无显著意义(P>0.05)。结论牙冠延长术有利于残根残冠的保存和修复,但要注意适应证的选择。 相似文献
46.
Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. 总被引:1,自引:0,他引:1
The aim of this study was to investigate the association between clinical variables and all-cause and respiratory mortality in patients with chronic obstructive pulmonary disease (COPD) undergoing long-term oxygen therapy (LTOT). The authors retrospectively studied a historic cohort of 128 patients with COPD (126 males, mean age+/-SD 68.9+/-9.7 yrs, body mass index (BMI) 25.1+/-4.5 kg.m-2, and forced expiratory volume in one second 25.4+/-8.8% predicted), who were being treated with long-term oxygen therapy in a tertiary teaching hospital between 1992 and 1999. Comorbidity, assessed with the Charlson Index, was present in 38% of the patients. Vital status and cause of death were assessed through the population death registry. A total of 78 patients (61%) had died by the end of follow-up. Three-year survival was 55%. Death was due to respiratory causes in 77% of cases. On Cox analysis, BMI<25 kg.m-2, comorbid conditions, age>or=70 yrs and cor pulmonale were associated with all-cause mortality. The BMI and comorbidity were the only significant predictive factors when the analysis was restricted to respiratory mortality. In conclusion, body mass index<25 kg.m-2 and comorbidity were predictors of all-cause and respiratory mortality in a cohort of chronic obstructive pulmonary disease patients treated with long-term oxygen therapy. These factors should be taken into account when considering the management and prognosis of these patients. 相似文献
47.
目的探讨参麦注射液治疗老年哮喘的临床价值。方法选择60例老年哮喘,随机分为参麦治疗组和常规对照组进行临床观察。结果参麦组肺功能(FVC、FEVI、VC、FEV%)在治疗后较治疗前明显增加,并有显著差异(p<0.01);对照组治疗前后对比差异无显著性(P>0.05);两组组间比较有显著性差异(P<0.05)。参麦组临床疗效及总有效率明显优于对照组(p<0.01),差异十分显著。结论参麦注射液对改善老年哮喘肺功能及缓解哮喘症状有较好疗效。 相似文献
48.
49.
A. HAZIOT I. KATZ G. W. RONG X. Y. LIN J. SILVER & S. M. GOYERT 《Scandinavian journal of immunology》1997,46(3):242-245
Membrane-bound CD14 acts as a receptor for lipopolysaccharide (LPS) on monocytes/macrophages and neutrophils. Studies have suggested that the activation of monocytes/macrophages by the binding of LPS to membrane-bound CD14 may require the association of a signal-transducing molecule with membrane-bound CD14. The observation that non-CD14 expressing cells, such as endothelial cells, can nevertheless be activated by a complex of LPS and a soluble form of CD14 (sCD14) suggests that the receptor for this complex may be identical to the signal transducing molecule associated with membrane-bound CD14. The studies described show that two CD14-specific MoAb are able to block the LPS-induced activation of endothelial cells but do not affect the response of monocytes to LPS. This suggests that the interaction of the sCD14:LPS complex with endothelial cells is distinct from the interaction of membrane-bound CD14 with its putative signal-transducing molecule. 相似文献
50.
Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. 总被引:6,自引:0,他引:6
下载免费PDF全文
![点击此处可从《The Journal of clinical investigation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
X Y Song M Gu W W Jin D M Klinman S M Wahl 《The Journal of clinical investigation》1998,101(12):2615-2621
Transforming growth factor beta is a potent immunomodulator with both pro- and antiinflammatory activities. Based on its immunosuppressive actions, exogenous TGF-beta has been shown to inhibit autoimmune and chronic inflammatory diseases. To further explore the potential therapeutic role of TGF-beta, we administered a plasmid DNA encoding human TGF-beta1 intramuscularly to rats with streptococcal cell wall-induced arthritis. A single dose of 300 microg plasmid DNA encoding TGF-beta1, but not vector DNA, administered at the peak of the acute phase profoundly suppressed the subsequent evolution of chronic erosive disease typified by disabling joint swelling and deformity (articular index = 8.17+/-0. 17 vs. 1.25+/-0.76, n = 6, day 26, P < 0.01). Moreover, delivery of the TGF-beta1 DNA even as the chronic phase commenced virtually eliminated subsequent inflammation and arthritis. Both radiologic and histopathologic as well as molecular evidence supported the marked inhibitory effect of TGF-beta1 DNA on synovial pathology, with decreases in the inflammatory cell infiltration, pannus formation, cartilage and bone destruction, and the expression of proinflammatory cytokines that characterize this model. Increases in TGF-beta1 protein were detected in the circulation of TGF-beta1 DNA-treated animals, consistent with the observed therapeutic effects being TGF-beta1 dependent. These observations provide the first evidence that gene transfer of plasmid DNA encoding TGF-beta1 provides a mechanism to deliver this potent cytokine that effectively suppresses ongoing inflammatory pathology in arthritis. 相似文献